Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mahase E. Lecanemab and donanemab: NICE reconsiders controversial Alzheimer's drugs. BMJ 2025;388:r463.
PMID: 40054859

Privacy Policy